Skip to content
Breaking News

Novartis expectations on bigger blockbusters to power growth, forecasting 5% annual sales through 2031

Drugmaker Novartis raised its peak sales forecast for three of its best-selling drugs on Thursday, referring to robust demand as it looks to offset the financial impact of older drugs' patent expiries. The upgrade comes as Novartis projected annual sales growth of 5% through 2031…

By FxGain News Editorial Desk · · 2 min read

Novartis news – Novartis expectations on bigger blockbusters to power growth, forecasting 5% annual sales through 2031
In this article
  1. What happened: Novartis news
  2. Why Novartis news matters for traders
  3. Market reaction and data
  4. What to watch next for Novartis news
  5. FAQ

In the latest Novartis news update, Drugmaker Novartis raised its peak sales forecast for three of its best-selling drugs on Thursday, referring to robust demand as it looks to offset the financial impact of older drugs' patent expiries, according to CNBC World. The upgrade comes as Novartis projected annual sales growth of 5% through 2031, a little less ambitious than its prior guidance of between 5% and 6% through 2030, even though it covers a different five-year period.

What happened: Novartis news

The Swiss drugmaker now projects multiple sclerosis drug Kesimpta, leukaemia treatment Scemblix, and cholesterol medicine Leqvio to generate $18 billion in peak sales, up from a prior forecast of $14 billion combined. CEO Vas Narasimhan noted the revised forward view reflected the expected entry of US generic competition for Kisqali, a breast cancer treatment, in the second half of 2031.

Why Novartis news matters for traders

News that changes the outlook for growth, inflation or interest rates can move currencies, bonds, commodities and stocks. Traders weigh each headline for what it means for central-bank policy and risk appetite.

Unexpected developments often lead to higher volatility, so position sizing and risk management become especially important around breaking news.

Market reaction and data

Crypto prices at the time of writing, from Binance spot data (2026-11-19 08:41 UTC):

AssetLast price (USDT)24h change24h high24h low
Bitcoin (BTC)63,683.68-1.58%64,809.5362,062.97
Ethereum (ETH)1,804.28-0.34%1,817.501,732.83

What to watch next for Novartis news

Traders will look for follow-up statements, official data and the reaction in major currency pairs, gold and stock indices.

Key scheduled releases on the economic calendar:

  • AUD Employment Change on Thu Nov 19, 00:30 UTC, forecast 25.5K, previous -39.3K
  • AUD Unemployment Rate on Thu Nov 19, 00:30 UTC, forecast 4.7%, previous 4.7%

Follow every update in our Top 10 Breaking Market News, read Geopolitical risk: Musk accuses Zelenskyy of lying about Starshield restrictions in Ukraine or see all of today's top market news.

FAQ

What is the latest Novartis news news?

Drugmaker Novartis raised its peak sales forecast for three of its best-selling drugs on Thursday, referring to robust demand as it looks to offset the financial impact of older drugs' patent expiries.

How should traders react to breaking news?

Wait for confirmation from reliable sources, watch how prices react around key levels and manage risk carefully, as spreads and volatility can rise sharply.

Where does this information come from?

This report is based on coverage from CNBC World, checked against market data where available. It is a summary for information only and not investment advice.

#Novartis news#Markets#Breaking News#CNBC World

Risk warning: This article is for information only and is not investment advice. Trading forex, CFDs, stocks and crypto carries a high risk of losing money. Prices move fast – check live quotes before you trade.

More Breaking News news

View all
Forex bonus offers
Forex deposit bonus